The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Two Straits, One Storm: Yemen, Iran, and the Unfinished Arithmetic of Adventurism
- Gynaecologist seeks stronger primary healthcare to cut maternal deaths
- Beyond the dance: Lessons from Osun 2026 for Nigeria 2027, by Prof. M.K. Othman
- Bwari riders decry motorcycle theft, seizures
- SDNON felicitates with member over appointment as head of media directorate for Delta NDC guber campaign
- States spend N35bn on flood, erosion control
- Of caps, marabouts and politics of envy, by Hassan Gimba
- FG scraps data charges for students on approved educational platforms
